Identifying the molecular determinants of adipocyte hypertrophy: Role of septin 11 in the remodelling of actin and microtubules and their interaction with lipid droplets during fat cell expansion.
Implementing Organization
University of Kerala
Principal Investigator
Dr. Renu Mohan
University of Kerala
About
Obesity, a metabolic disorder linked to various diseases, has significantly increased in recent years, particularly in India. It involves adipose tissue growth, including hypertrophy and hyperplasia of fat cells. Hypertrophic obesity is related to obesity-associated disorders. A critical step in adipocyte hypertrophy is cytoskeleton remodelling, which increases lipid storage capability and prevents lipid overload. Cytoskeletal components actin, tubulin, and vimentin undergo important changes during adipogenesis and adipocyte hypertrophy. Actin cooperates with microtubules during various stages of adipocyte hypertrophy, including lipid droplet growth and transportation. However, the exact mechanism behind this combinatory contribution to fat cell expansion remains unknown. septins, GTP-binding proteins, can interact with both actin and microtubules and assemble into higher order cytoskeletal structures. septin 11, a member of the septin family, was upregulated in adipocytes during obesity and correlated with insulin resistance in subcutaneous adipose tissue. septins are crucial for lipid droplet biogenesis from the endoplasmic reticulum but are the least studied cytoskeletal type in eukaryotic cells. The hypothesis is that septins mediates the crosstalk between lipid droplet and cytoskeletal reorganisation, regulating structural rearrangements of the actin-microtubule cytoskeletal system in accordance with lipid droplet expansion. The primary objective is to evaluate whether septins, specifically septin11, is implicated in the link between lipid droplet enlargement and cytoskeletal reorganisation during adipocyte hypertrophy.
Source
Source
Anusandhan National Research Foundation/science and Engineering Research Board (sERB), DsT 2023-24
Science and Engineering Research Board (SERB), New Delhi
Anusandhan National Research Foundation (ANRF)
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Year
2023
End Year
2026
Sanction Amount
₹ 26.24 L
Status
Ongoing
Contact
renumohanrm@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.